The market today is being driven by a mix of positive and negative factors, resulting in a relatively flat performance for the mid cap segment. Exide Industries and Sona BLW Precision have both been upgraded from a "hold" to a "buy" rating, indicating potential for growth in the near future. However, the overall mid cap index (BSE midcap) has seen a slight decline of -0.19% today and a larger decline of -1.34% in the last 5 days. This can be attributed to the current market volatility and uncertainty surrounding the COVID-19 pandemic. Despite this, the mid cap segment has been the best performer, with Yes Bank showing a return of 3.95%. On the other hand, Glaxosmithkline Pharmaceuticals has been the worst performer with a return of -3.27%. Looking at the advance-decline ratio, we can see that 49 stocks are advancing while 73 stocks are declining, with a ratio of 0.67x. This indicates a mixed sentiment among investors in the mid cap segment. In terms of stock upgrades, Sona BLW Precision has been upgraded from mildly bearish to mildly bullish, while L&T Finance Holdings, Schaeffler India, L&T Technology, and Gland Pharma have all been upgraded from bullish to mildly bullish. This suggests that these stocks may see some positive movement in the near future. Overall, the mid cap segment is facing some challenges but also showing potential for growth. Investors should carefully consider their options and keep an eye on market trends before making any investment decisions.